Global Low Molecular Weight Heparin Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

Global Low Molecular Weight Heparin Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030


Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.

Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.

According to APO Research, The global Low Molecular Weight Heparin market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Global Low Molecular Weight Heparin main players are Aspen, Sanofi-aventis, CSBIO, Dongying Tiandong Pharmaceutical, Techdow, etc. Top five companies hold a share above 55%. Europe is the largest market, with a share about 35%.

In terms of production side, this report researches the Low Molecular Weight Heparin production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Low Molecular Weight Heparin by region (region level and country level), by company, by type and by application. from 2019 to 2024 and forecast to 2030.

This report presents an overview of global market for Low Molecular Weight Heparin, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Low Molecular Weight Heparin, also provides the consumption of main regions and countries. Of the upcoming market potential for Low Molecular Weight Heparin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Low Molecular Weight Heparin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Low Molecular Weight Heparin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Low Molecular Weight Heparin sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow and Yantai Dongcheng Pharmaceutical Group, etc.

Low Molecular Weight Heparin segment by Company

Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Low Molecular Weight Heparin segment by Type

Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine

Low Molecular Weight Heparin segment by Application

Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others

Low Molecular Weight Heparin segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Low Molecular Weight Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Low Molecular Weight Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Low Molecular Weight Heparin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Low Molecular Weight Heparin market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Low Molecular Weight Heparin industry.
Chapter 3: Detailed analysis of Low Molecular Weight Heparin market competition landscape. Including Low Molecular Weight Heparin manufacturers' output value, output and average price from 2019 to 2024, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Low Molecular Weight Heparin by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Low Molecular Weight Heparin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Low Molecular Weight Heparin Production Value Estimates and Forecasts (2019-2030)
1.2.2 Global Low Molecular Weight Heparin Production Capacity Estimates and Forecasts (2019-2030)
1.2.3 Global Low Molecular Weight Heparin Production Estimates and Forecasts (2019-2030)
1.2.4 Global Low Molecular Weight Heparin Market Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Global Low Molecular Weight Heparin Market Dynamics
2.1 Low Molecular Weight Heparin Industry Trends
2.2 Low Molecular Weight Heparin Industry Drivers
2.3 Low Molecular Weight Heparin Industry Opportunities and Challenges
2.4 Low Molecular Weight Heparin Industry Restraints
3 Low Molecular Weight Heparin Market by Manufacturers
3.1 Global Low Molecular Weight Heparin Production Value by Manufacturers (2019-2024)
3.2 Global Low Molecular Weight Heparin Production by Manufacturers (2019-2024)
3.3 Global Low Molecular Weight Heparin Average Price by Manufacturers (2019-2024)
3.4 Global Low Molecular Weight Heparin Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Low Molecular Weight Heparin Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Low Molecular Weight Heparin Manufacturers, Product Type & Application
3.7 Global Low Molecular Weight Heparin Manufacturers Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Low Molecular Weight Heparin Market CR5 and HHI
3.8.2 Global Top 5 and 10 Low Molecular Weight Heparin Players Market Share by Production Value in 2023
3.8.3 2023 Low Molecular Weight Heparin Tier 1, Tier 2, and Tier 3
4 Low Molecular Weight Heparin Market by Type
4.1 Low Molecular Weight Heparin Type Introduction
4.1.1 Enoxaparin
4.1.2 Dalteparin
4.1.3 Tinzaparin
4.1.4 Fraxiparine
4.2 Global Low Molecular Weight Heparin Production by Type
4.2.1 Global Low Molecular Weight Heparin Production by Type (2019 VS 2023 VS 2030)
4.2.2 Global Low Molecular Weight Heparin Production by Type (2019-2030)
4.2.3 Global Low Molecular Weight Heparin Production Market Share by Type (2019-2030)
4.3 Global Low Molecular Weight Heparin Production Value by Type
4.3.1 Global Low Molecular Weight Heparin Production Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Low Molecular Weight Heparin Production Value by Type (2019-2030)
4.3.3 Global Low Molecular Weight Heparin Production Value Market Share by Type (2019-2030)
5 Low Molecular Weight Heparin Market by Application
5.1 Low Molecular Weight Heparin Application Introduction
5.1.1 Treatment of Venous Thromboembolism
5.1.2 Complications of Pregnancy
5.1.3 Cardioversion of Atrial Fibrillation/Flutter
5.1.4 Others
5.2 Global Low Molecular Weight Heparin Production by Application
5.2.1 Global Low Molecular Weight Heparin Production by Application (2019 VS 2023 VS 2030)
5.2.2 Global Low Molecular Weight Heparin Production by Application (2019-2030)
5.2.3 Global Low Molecular Weight Heparin Production Market Share by Application (2019-2030)
5.3 Global Low Molecular Weight Heparin Production Value by Application
5.3.1 Global Low Molecular Weight Heparin Production Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Low Molecular Weight Heparin Production Value by Application (2019-2030)
5.3.3 Global Low Molecular Weight Heparin Production Value Market Share by Application (2019-2030)
6 Company Profiles
6.1 Aspen
6.1.1 Aspen Comapny Information
6.1.2 Aspen Business Overview
6.1.3 Aspen Low Molecular Weight Heparin Production, Value and Gross Margin (2019-2024)
6.1.4 Aspen Low Molecular Weight Heparin Product Portfolio
6.1.5 Aspen Recent Developments
6.2 Sanofi-aventis
6.2.1 Sanofi-aventis Comapny Information
6.2.2 Sanofi-aventis Business Overview
6.2.3 Sanofi-aventis Low Molecular Weight Heparin Production, Value and Gross Margin (2019-2024)
6.2.4 Sanofi-aventis Low Molecular Weight Heparin Product Portfolio
6.2.5 Sanofi-aventis Recent Developments
6.3 Pfizer
6.3.1 Pfizer Comapny Information
6.3.2 Pfizer Business Overview
6.3.3 Pfizer Low Molecular Weight Heparin Production, Value and Gross Margin (2019-2024)
6.3.4 Pfizer Low Molecular Weight Heparin Product Portfolio
6.3.5 Pfizer Recent Developments
6.4 Opocrin
6.4.1 Opocrin Comapny Information
6.4.2 Opocrin Business Overview
6.4.3 Opocrin Low Molecular Weight Heparin Production, Value and Gross Margin (2019-2024)
6.4.4 Opocrin Low Molecular Weight Heparin Product Portfolio
6.4.5 Opocrin Recent Developments
6.5 CSBIO
6.5.1 CSBIO Comapny Information
6.5.2 CSBIO Business Overview
6.5.3 CSBIO Low Molecular Weight Heparin Production, Value and Gross Margin (2019-2024)
6.5.4 CSBIO Low Molecular Weight Heparin Product Portfolio
6.5.5 CSBIO Recent Developments
6.6 Dongying Tiandong Pharmaceutical
6.6.1 Dongying Tiandong Pharmaceutical Comapny Information
6.6.2 Dongying Tiandong Pharmaceutical Business Overview
6.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Production, Value and Gross Margin (2019-2024)
6.6.4 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product Portfolio
6.6.5 Dongying Tiandong Pharmaceutical Recent Developments
6.7 Changzhou Qianhong Bio-pharma
6.7.1 Changzhou Qianhong Bio-pharma Comapny Information
6.7.2 Changzhou Qianhong Bio-pharma Business Overview
6.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Production, Value and Gross Margin (2019-2024)
6.7.4 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product Portfolio
6.7.5 Changzhou Qianhong Bio-pharma Recent Developments
6.8 Techdow
6.8.1 Techdow Comapny Information
6.8.2 Techdow Business Overview
6.8.3 Techdow Low Molecular Weight Heparin Production, Value and Gross Margin (2019-2024)
6.8.4 Techdow Low Molecular Weight Heparin Product Portfolio
6.8.5 Techdow Recent Developments
6.9 Yantai Dongcheng Pharmaceutical Group
6.9.1 Yantai Dongcheng Pharmaceutical Group Comapny Information
6.9.2 Yantai Dongcheng Pharmaceutical Group Business Overview
6.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Production, Value and Gross Margin (2019-2024)
6.9.4 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product Portfolio
6.9.5 Yantai Dongcheng Pharmaceutical Group Recent Developments
7 Global Low Molecular Weight Heparin Production by Region
7.1 Global Low Molecular Weight Heparin Production by Region: 2019 VS 2023 VS 2030
7.2 Global Low Molecular Weight Heparin Production by Region (2019-2030)
7.2.1 Global Low Molecular Weight Heparin Production by Region: 2019-2024
7.2.2 Global Low Molecular Weight Heparin Production by Region (2025-2030)
7.3 Global Low Molecular Weight Heparin Production by Region: 2019 VS 2023 VS 2030
7.4 Global Low Molecular Weight Heparin Production Value by Region (2019-2030)
7.4.1 Global Low Molecular Weight Heparin Production Value by Region: 2019-2024
7.4.2 Global Low Molecular Weight Heparin Production Value by Region (2025-2030)
7.5 Global Low Molecular Weight Heparin Market Price Analysis by Region (2019-2024)
7.6 Regional Production Value Trends (2019-2030)
7.6.1 North America Low Molecular Weight Heparin Production Value (2019-2030)
7.6.2 Europe Low Molecular Weight Heparin Production Value (2019-2030)
7.6.3 Asia-Pacific Low Molecular Weight Heparin Production Value (2019-2030)
7.6.4 Latin America Low Molecular Weight Heparin Production Value (2019-2030)
7.6.5 Middle East & Africa Low Molecular Weight Heparin Production Value (2019-2030)
8 Global Low Molecular Weight Heparin Consumption by Region
8.1 Global Low Molecular Weight Heparin Consumption by Region: 2019 VS 2023 VS 2030
8.2 Global Low Molecular Weight Heparin Consumption by Region (2019-2030)
8.2.1 Global Low Molecular Weight Heparin Consumption by Region (2019-2024)
8.2.2 Global Low Molecular Weight Heparin Consumption by Region (2025-2030)
8.3 North America
8.3.1 North America Low Molecular Weight Heparin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
8.3.2 North America Low Molecular Weight Heparin Consumption by Country (2019-2030)
8.3.3 U.S.
8.3.4 Canada
8.4 Europe
8.4.1 Europe Low Molecular Weight Heparin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
8.4.2 Europe Low Molecular Weight Heparin Consumption by Country (2019-2030)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Netherlands
8.5 Asia Pacific
8.5.1 Asia Pacific Low Molecular Weight Heparin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
8.5.2 Asia Pacific Low Molecular Weight Heparin Consumption by Country (2019-2030)
8.5.3 China
8.5.4 Japan
8.5.5 South Korea
8.5.6 Southeast Asia
8.5.7 India
8.5.8 Australia
8.6 LAMEA
8.6.1 LAMEA Low Molecular Weight Heparin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
8.6.2 LAMEA Low Molecular Weight Heparin Consumption by Country (2019-2030)
8.6.3 Mexico
8.6.4 Brazil
8.6.5 Turkey
8.6.6 GCC Countries
9 Value Chain and Sales Channels Analysis
9.1 Low Molecular Weight Heparin Value Chain Analysis
9.1.1 Low Molecular Weight Heparin Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Low Molecular Weight Heparin Production Mode & Process
9.2 Low Molecular Weight Heparin Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Low Molecular Weight Heparin Distributors
9.2.3 Low Molecular Weight Heparin Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings